Pacific Biosciences of California

Pacific Biosciences of California

Yahoo Finance • 2 days ago

Stocks making big moves yesterday: TTM Technologies, PacBio, Nvidia, Palo Alto Networks, and Teleflex

Stocks making big moves yesterday: TTM Technologies, PacBio, Nvidia, Palo Alto Networks, and Teleflex Check out the companies making headlines yesterday: PacBio (NASDAQ:PACB): Genomics company Pacific Biosciences of California (NASDAQ:PA... Full story

Yahoo Finance • 13 days ago

Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today

Pacific Biosciences of California (PACB) closed at $1.38 in the latest trading session, marking a +2.99% move from the prior day. This change outpaced the S&P 500's 1.14% gain on the day. Meanwhile, the Dow gained 0.61%, and the Nasdaq, a... Full story

Yahoo Finance • 29 days ago

3 Reasons to Sell PACB and 1 Stock to Buy Instead

3 Reasons to Sell PACB and 1 Stock to Buy Instead Shareholders of PacBio would probably like to forget the past six months even happened. The stock dropped 20.5% and now trades at $1.29. This was partly due to its softer quarterly results... Full story

Yahoo Finance • last month

Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned.

Quick Read MRK and MRNA's intismeran autogene beat Keytruda alone on recurrence-free survival in Phase 3 melanoma, though no specific efficacy numbers have been released yet. BNTX surged 21% on read-across excitement, while ILMN rose 16%... Full story

Yahoo Finance • last month

1 Healthcare Stock to Target This Week and 2 Facing Headwinds

1 Healthcare Stock to Target This Week and 2 Facing Headwinds Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and the... Full story

Yahoo Finance • 2 months ago

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry and an accompanying software upda... Full story

Yahoo Finance • 2 months ago

PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference 

MENLO PARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Canaccord... Full story

Yahoo Finance • 4 months ago

Is Pacific Biosciences of California, Inc. (PACB) One of the Best Genomics Stocks to Buy According to Wall Street?

Pacific Biosciences of California, Inc. (NASDAQ:PACB) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On May 26, Pacific Biosciences of California, Inc. (NASDAQ:PACB) began global shipments of its SPRQ-Nx sequencing che... Full story

Yahoo Finance • 4 months ago

PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing

PacBio New Revio multi-use SMRT Cells reduce sequencing costs by 30% compared to previous SPRQ chemistry while DeepConsensus improvements and expanded methylation calling increase accuracy, yield, and epigenetic insight MENLO PARK, Calif... Full story

Yahoo Finance • 5 months ago

PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing

MENLO PARK, Calif. & BERLIN, April 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a premier developer of sequencing solutions, and Lucid Genomics GmbH, a provider of cutting-edge bioinformatics software for clinical and research gen... Full story

Yahoo Finance • 7 months ago

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. The retreat in oil prices provided temporary relief to a market that was volatil... Full story

Yahoo Finance • 7 months ago

Why The PacBio (PACB) Investment Story Is Shifting As Analysts Cut Targets And Flag Risks

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Pacific Biosciences of California is back in focus after analysts cut their price target to $1.5... Full story

Yahoo Finance • 7 months ago

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key measure of inflation at t... Full story

Yahoo Finance • 7 months ago

Genomics Stocks That Deserve a Place in Your Portfolio in 2026

An updated edition of the Jan. 6, 2026, article. Genomics is the comprehensive study of genomes—the complete set of deoxyribonucleic acid (DNA) within an organism. Rapid scientific progress in this field has intensified interest among pha... Full story

Yahoo Finance • 9 months ago

PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference

PacBio MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morg... Full story

Yahoo Finance • 9 months ago

TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock

This article first appeared on GuruFocus. Cathie Wood's Ark Invest increased stakes in gene-editing and autonomous mobility companies while trimming holdings in Tesla (NASDAQ:TSLA) and Rocket Lab (NASDAQ:RKLB). Selling activity focused o... Full story

Yahoo Finance • 9 months ago

Cathie Wood invests heavily in gene-editing companies, offloads $30 million worth Tesla stock

[Bitcoin 2022 Conference Draws Cryptocurrency Industry Professionals And Investors To Miami] Marco Bello Cathie Wood’s Ark Invest increased exposure to gene-editing names and autonomous mobility companies while further cutting holdings in... Full story

Yahoo Finance • 10 months ago

PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference

MENLO PARK, Calif., Nov. 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at Piper Sandler’... Full story

Yahoo Finance • 11 months ago

PacBio Announces Third Quarter 2025 Financial Results

MENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2025. Third quarter results: Q32025Q32024Revenue$38.4 million$40.0 millionInstrument reve... Full story

Yahoo Finance • 11 months ago

PacBio (PACB): Valuation in Focus After World-First NMPA Approval for Clinical Long-Read Sequencer in China

Pacific Biosciences of California (PACB) just hit a worldwide milestone after their Sequel II CNDx system, developed with Berry Genomics, gained Class III Medical Device approval from China's NMPA. This means clinical-grade long-read seque... Full story